These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23480235)

  • 21. Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
    van Westen GJ; van den Hoven OO; van der Pijl R; Mulder-Krieger T; de Vries H; Wegner JK; Ijzerman AP; van Vlijmen HW; Bender A
    J Med Chem; 2012 Aug; 55(16):7010-20. PubMed ID: 22827545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrimidin-8-on[2,1-f]theophylline-9-alkylcarboxylic acids amides as A1 and A2A adenosine receptor ligands.
    Fhid O; Pawlowski M; Jurczyk S; Muller CE; Schumacher B
    Farmaco; 2003 Jun; 58(6):439-44. PubMed ID: 12767383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects of substitution pattern of phenyl substituents on affinity for adenosine A(1) and A(2A) receptors.
    Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
    Eur J Med Chem; 2009 May; 44(5):2122-7. PubMed ID: 19036477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
    Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
    Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.
    Giorgi I; Bianucci AM; Biagi G; Livi O; Scartoni V; Leonardi M; Pietra D; Coi A; Massarelli I; Nofal FA; Fiamingo FL; Anastasi P; Giannini G
    Eur J Med Chem; 2007 Jan; 42(1):1-9. PubMed ID: 17028066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A
    Legoabe LJ; Van der Walt MM; Terre'Blanche G
    Chem Biol Drug Des; 2018 Jan; 91(1):234-244. PubMed ID: 28734058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides.
    Inamdar GS; Pandya AN; Thakar HM; Sudarsanam V; Kachler S; Sabbadin D; Moro S; Klotz KN; Vasu KK
    Eur J Med Chem; 2013 May; 63():924-34. PubMed ID: 23685887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling study on potent and selective adenosine A(3) receptor agonists.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
    Bioorg Med Chem; 2010 Nov; 18(22):7923-30. PubMed ID: 20943397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Substituted 2-benzylidene-1-tetralone analogues as A
    Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ
    Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
    Lenzi O; Colotta V; Catarzi D; Varano F; Poli D; Filacchioni G; Varani K; Vincenzi F; Borea PA; Paoletta S; Morizzo E; Moro S
    J Med Chem; 2009 Dec; 52(23):7640-52. PubMed ID: 19743865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A3 adenosine receptor: homology modeling and 3D-QSAR studies.
    Almerico AM; Tutone M; Pantano L; Lauria A
    J Mol Graph Model; 2013 May; 42():60-72. PubMed ID: 23567933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity.
    Yadav R; Bansal R; Kachler S; Klotz KN
    Eur J Med Chem; 2014 Mar; 75():327-35. PubMed ID: 24556147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of 8-(cyclopentyloxy)phenyl substituted xanthine derivatives as adenosine A2A ligands.
    Bansal R; Kumar G; Gandhi D; Yadav R; Young LC; Harvey AL
    Arzneimittelforschung; 2010; 60(3):131-6. PubMed ID: 20422944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
    Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G
    Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Covalent, Clickable Probes for Adenosine A
    Trinh PNH; Chong DJW; Leach K; Hill SJ; Tyndall JDA; May LT; Vernall AJ; Gregory KJ
    J Med Chem; 2021 Jun; 64(12):8161-8178. PubMed ID: 34120444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.